Answers are grounded in this paper and cite their sources.
Approximately half of patients receiving I/T/DIN/GM-CSF for relapsed HRNB had objective responses. Patients with initial SD were unlikely to have an objective response, but > 1 of 3 patients with MR/PR on first evaluation ultimately had complete response. I/T/DIN/GM-CSF was associated with extended PFS in responders both during and after discontinuation of treatment. This study establishes a new comparator for response and survival in patients with relapsed HRNB.
No takes yet. Share an insight, caveat, or question.
Lerman et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: